RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
57.78
+0.03 (0.05%)
Feb 4, 2026, 3:14 PM EST - Market open
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $1.79 billion as of February 4, 2026. Its market cap has increased by 1,003.25% in one year.
Market Cap
1.79B
Enterprise Value
1.63B
1-Year Change
1,003.25%
Ranking
Category
Stock Price
$57.78
Market Cap Chart
Since October 31, 2019, RAPT Therapeutics's market cap has increased from $276.64M to $1.79B, an increase of 545.86%. That is a compound annual growth rate of 34.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 1.79B | 90.27% |
| Dec 31, 2025 | 938.57M | 340.16% |
| Dec 31, 2024 | 213.23M | -75.05% |
| Dec 29, 2023 | 854.75M | 27.19% |
| Dec 30, 2022 | 672.02M | -38.08% |
| Dec 31, 2021 | 1.09B | 123.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precigen | 1.71B |
| Oculis Holding AG | 1.68B |
| Enliven Therapeutics | 1.67B |
| Immunocore Holdings | 1.67B |
| Oruka Therapeutics | 1.66B |
| Tyra Biosciences | 1.66B |
| Monte Rosa Therapeutics | 1.65B |
| Agios Pharmaceuticals | 1.64B |